Search

Tyron Tai-Chun Chou,1,* Hsin-Chien Hsu,1– 3,* Chih-Wen Twu,4,5 Wen-Kuan Huang,6 Hung-Meng Huang,1,7 Shih-Han Weng,8 Ming-Chih Chen2 1Department of Otolaryngology, Taipei City Hospital, Taipei City, Taiwan; 2Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, New Taipei City, Taiwan; 3General Education Center, University of Taipei, Taipei City, Taiwan; 4Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua County, Taiwan; 5Department of Post-Baccalaureate Medicine, National Chung Hsing University, Taichung City, Taiwan; 6Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan City, Taiwan; 7Department of Otolaryngology, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan; 8Department of Education and Research, Taipei City Hospital, Taipei City, Taiwan*These authors contributed equally to this workCorrespondence: Ming-Chih Chen, Institute of Business Administration, College of Management, Fu Jen Catholic University, No. 510, Zhongzheng Road, Xinzhuang District, New Taipei City, 242062, Taiwan, Email 081438@mail.fju.edu.twBackground: Obstructive sleep apnea syndrome (OSAS) is a common disorder associated with serious sequelae. The current gold standard diagnostic method, polysomnography, is costly and time consuming and requires patients to stay overnight at a facility.Aim: This study aimed to reveal the prevalence of OSAS in general adult population using a home sleep test (HST) during the coronavirus disease 2019 (COVID-19) pandemic.Methods: This prospective cohort study was conducted by the Department of Otolaryngology, Taipei City Hospital, Taipei, Taiwan, between January 2020 and December 2021. A total of 1372 patients aged 30– 70 years completed an HST using a Type 3 portable sleep monitor (PM). The apnea-hypopnea